Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher B Granger

Showing results (421-430 of 910) with videos related to

Pageof 91
Sort By:
JAMA Internal Medicine|December 9, 2014
Fibrinolysis use among patients requiring interhospital transfer for ST-segment elevation myocardial infarction care: a report from the US National Cardiovascular Data RegistryAmit N Vora, DaJuanicia N Holmes, Ivan Rokos, et al.
Prehospital Emergency Care|March 18, 2016
Therapeutic Hypothermia for Patients with Out-of-Hospital Cardiac Arrest in North CarolinaMeena P Rao, Matthew E Dupre, Sean D Pokorney, et al.
Circulation|October 9, 2014
Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trialLars Wallentin, Ziad Hijazi, Ulrika Andersson, et al.
European Journal of Internal Medicine|February 19, 2026
Major adverse cardiovascular and bleeding outcomes in paroxysmal vs. non-paroxysmal atrial fibrillation: an individual patient-level data analysis of a large cohort of patients from the COMBINE-AFGeorge Ntaios, Andreas Goette, Michael G Palazzolo, et al.
Circulation|August 20, 2003
Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trialChristopher B Granger, Kenneth W Mahaffey, W Douglas Weaver, et al.
Journal of the American Heart Association|December 7, 2021
Efficacy and Safety of Antithrombotic Therapy in Patients With Atrial Fibrillation, Recent Acute Coronary Syndrome, or Percutaneous Coronary Intervention and a History of Heart Failure: Insights From the AUGUSTUS TrialMarat Fudim, Daniel M Wojdyla, John H Alexander, et al.
Circulation. Cardiovascular Quality and Outcomes|February 10, 2011
Mortality implications of primary percutaneous coronary intervention treatment delays: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trialMichael P Hudson, Paul W Armstrong, William W O'Neil, et al.
European Heart Journal|December 3, 2009
Resolution of ST-segment depression: A new prognostic marker in ST-segment elevation myocardial infarctionMichael C Tjandrawidjaja, Yuling Fu, Cynthia M Westerhout, et al.
Journal of Thrombosis and Thrombolysis|June 5, 2013
Warfarin use and long-term outcomes in patients with acute myocardial infarction and atrial fibrillationJames A Nelson, John P Vavalle, Christopher H May, et al.
The American Journal of Cardiology|December 26, 2007
International variation in the use of blood transfusion in patients with non-ST-segment elevation acute coronary syndromesSunil V Rao, Karen Chiswell, Jie-Lena Sun, et al.
Pageof 91

Showing results (421-430 of 910) with videos related to

Sort By:
Pageof 91
JAMA Internal Medicine|December 9, 2014
Fibrinolysis use among patients requiring interhospital transfer for ST-segment elevation myocardial infarction care: a report from the US National Cardiovascular Data RegistryAmit N Vora, DaJuanicia N Holmes, Ivan Rokos, et al.
Prehospital Emergency Care|March 18, 2016
Therapeutic Hypothermia for Patients with Out-of-Hospital Cardiac Arrest in North CarolinaMeena P Rao, Matthew E Dupre, Sean D Pokorney, et al.
Circulation|October 9, 2014
Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trialLars Wallentin, Ziad Hijazi, Ulrika Andersson, et al.
European Journal of Internal Medicine|February 19, 2026
Major adverse cardiovascular and bleeding outcomes in paroxysmal vs. non-paroxysmal atrial fibrillation: an individual patient-level data analysis of a large cohort of patients from the COMBINE-AFGeorge Ntaios, Andreas Goette, Michael G Palazzolo, et al.
Circulation|August 20, 2003
Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trialChristopher B Granger, Kenneth W Mahaffey, W Douglas Weaver, et al.
Journal of the American Heart Association|December 7, 2021
Efficacy and Safety of Antithrombotic Therapy in Patients With Atrial Fibrillation, Recent Acute Coronary Syndrome, or Percutaneous Coronary Intervention and a History of Heart Failure: Insights From the AUGUSTUS TrialMarat Fudim, Daniel M Wojdyla, John H Alexander, et al.
Circulation. Cardiovascular Quality and Outcomes|February 10, 2011
Mortality implications of primary percutaneous coronary intervention treatment delays: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trialMichael P Hudson, Paul W Armstrong, William W O'Neil, et al.
European Heart Journal|December 3, 2009
Resolution of ST-segment depression: A new prognostic marker in ST-segment elevation myocardial infarctionMichael C Tjandrawidjaja, Yuling Fu, Cynthia M Westerhout, et al.
Journal of Thrombosis and Thrombolysis|June 5, 2013
Warfarin use and long-term outcomes in patients with acute myocardial infarction and atrial fibrillationJames A Nelson, John P Vavalle, Christopher H May, et al.
The American Journal of Cardiology|December 26, 2007
International variation in the use of blood transfusion in patients with non-ST-segment elevation acute coronary syndromesSunil V Rao, Karen Chiswell, Jie-Lena Sun, et al.
Pageof 91